REG - Life Science REIT - Appointment of new team members

Life Science ReitAnnouncement

28/05/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240528:nRSb9256Pa&default-theme=true

RNS Number : 9256P  Life Science REIT PLC  28 May 2024

28 May 2024

LEI: 213800RG7JNX7K8F7525

Life Science REIT plc

("Life Science REIT" or the "Company")

Investment Adviser appointments

Appointment of new team members

Life Science REIT (LSE: LABS), the real estate investment trust focused on UK
life sciences properties, is pleased to announce two new appointments to
Ironstone Asset Management, the Company's Investment Adviser.

Alex Wilshaw has joined as Associate Director - Asset Management following
five years as an asset manager at Tilstone Partners, the Investment Adviser to
Warehouse REIT. Alex specialises in asset management and investment projects
and will apply these skills to drive key initiatives across the portfolio.

Alex Lowdell, an experienced leasing specialist with particular expertise in
life sciences, has joined as Associate Director - Leasing.  Alex spent nine
years at DTRE in the Office, Science and Technology leasing team, focused on
the Golden Triangle of Oxford, Cambridge and London's Knowledge Quarter.

With over 140,000 sq ft of life science space completed at Oxford Technology
Park ("OTP") since 1 January 2023 or repurposed elsewhere on the portfolio,
these appointments significantly strengthen the team as the Company moves to
the next phase of its development and further accelerates leasing activity.

Simon Farnsworth, Managing Director of Ironstone Asset Management, the
Company's Investment Adviser, said: "These appointments come at a very
exciting time. We have made great progress at OTP and have recently commenced
the repurposing of fully fitted lab space at Cambourne which marks a major
step forward for that project. Investing in our team will further accelerate
the strong progress already made in leasing activity and the many asset
management initiatives underway."

END

Enquiries:

 Ironstone Asset Management - Investment Adviser                       +44 20 3011 2160
 Simon Farnsworth, Managing Director

 Simon.farnsworth@ironstoneam.com

 Joanna Waddingham, Head of Investor Relations and Corporate Affairs
 Joanna.Waddingham@ironstoneam.com

 Link Company Matters Limited - Company Secretary
 labs_cosec@linkgroup.co.uk

 Panmure Gordon (UK) Limited - Joint Corporate Broker                 +44 20 7886 2500
 Alex Collins / Tom Scrivens

 Jefferies International Limited - Joint Corporate Broker             +44 20 7029 8000
 Tom Yeadon / Oliver Nott

 G10 Capital Limited - AIFM                                           +44 20 7397 5450
 Maria Baldwin

 Buchanan - Financial PR                                              +44 20 7466 5000
 Mark Court / Henry Wilson / Verity Parker
 LifeSciencereit@buchanan.uk.com

 

Notes to editors

Life Science REIT plc is a specialist property business focused on the UK's
growing life science sector. The Company's portfolio of assets is located
across the "Golden Triangle" of research and development hubs in Oxford,
Cambridge and London's Knowledge Quarter and its strategic vision is to become
the property provider of choice for life science companies in the UK.

Life Science REIT is addressing the acute demand-supply imbalance for
laboratory space in the "Golden Triangle", which is characterised by low
vacancy rates and prime rental increases. The UK life science sector itself is
underpinned by strong structural drivers, including an ageing population and a
supportive regulatory environment as well as the growing interdependence with
technology, which is expanding the life science spectrum, driving strong
demand for laboratory space.

The Company's diverse portfolio of assets ranges from a 20-acre science park
currently under development through to fully let buildings, with an important
part of the Company's strategy being the conversion of existing properties to
laboratory space.

The Company's investment policy is focused on capital growth whilst also
providing a growing level of income.

Life Science REIT trades on the Main Market of the London Stock Exchange under
the ticker LABS.

Further information is available at https://lifesciencereit.co.uk
(https://lifesciencereit.co.uk/) . To sign up for email alerts, please visit
https://lifesciencereit.co.uk/investors/
(https://lifesciencereit.co.uk/investors/) .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPUBPAUPCGQC